Welcome to Hologic Investor Relations

 Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent and Upcoming Events
Recent News
Jan 13, 2017

MARLBOROUGH, Mass., Jan.12, 2017 – Despite significant progress in reducing cervical cancer rates in recent decades, thousands of women still die from the disease each year, and additionally,...

Jan 5, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2017 on Wednesday, February 1, 2017, after the market closes....

Jan 4, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that Jan Verstreken has been named Regional President for Europe, Middle East and Africa (EMEA) and Canada. Mr. Verstreken's appointment completes...

Jan 3, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted PMA approval for the Company's HIV-1 viral load monitoring assay. The Aptima® HIV-1 Quant...

More ›